Australia

Telix Briefing: Innovation in Urology to Feature Key Opinion Leaders in Prostate and Kidney Cancer

June 21, 2023, at The Yale Club, New York City  Featured speakers and Key Opinion Leaders include: Dr Christian Behrenbruch, DrColin Hayward, Kevin Richardson, Dr Brian Shuch and Dr Scott Tagawa Topics include Telix's urologic pipeline, development of novel therapeutics, imaging agents and techn...

2023-06-15 19:00 1871

Seeing Machines to highlight advantages of camera-based driver monitoring at InCabin in Brussels

CANBERRA, Australia, June 15, 2023 /PRNewswire/ -- Seeing Machines, an advanced computer vision technology company that designs AI-powered systems to improve transport safety, is excited to announce that it will be attending InCabin, held this year inBrussels from 20 – 22 June. Seeing Machines...

2023-06-15 14:00 1983

upGrad enters Pacific Region to set up the largest Institute of Medical Sciences

ATLANTA, June 13, 2023 /PRNewswire/ -- upGrad, Asia's largest integrated learning skilling and workforce development company announced the setting up of upGrad Institute of Medical Sciences (UIMS), a fully-offline campus in the Republic ofVanuatu to attract and train global talent with modern-day...

2023-06-13 19:08 2064

Approved: Merger between Armaguard and Prosegur Australia will improve sustainable supply of cash in Australia

*  The merger between Prosegur Australia and Armaguard will strengthen the sustainability of cash supply in the Australian economy, ensuring the availability of this key payment method for consumers and businesses. SYDNEY, June 13, 2023 /PRNewswire/ -- Prosegur Australia Holdings Limited, a lea...

2023-06-13 09:36 2053

FlexRule®, the strongest contender, offers a mighty Decision Platform, says Forrester

MELBOURNE, Australia, June 7, 2023 /PRNewswire/ -- Forrester recognized FlexRule®, a rapidly growing end-to-end decision management and automation provider, as "a good fit for customers that want a solid, comprehensive decisioning platform" in theForrester Wave™: AI Decisioning Platforms, Q2 2023...

2023-06-08 11:00 2037

Trajan's Microsampling Devices Meet IVDR Compliance in Europe, UK

Mitra® and hemaPEN® receive regulatory certification as medical devices for remote blood sample collection in healthcare, clinical trials and home monitoring programs inEurope and United Kingdom. MELBOURNE, Australia, June 2, 2023 /PRNewswire/ -- Trajan Scientific and Medical, a leading provider...

2023-06-02 20:00 2846

Aravax doses first patient in Phase 2 peanut allergy clinical trials

MELBOURNE, Australia, June 1, 2023 /PRNewswire/ -- The first patient has been dosed in a Phase 2 study (AVX-201) being run by biotechnology company Aravax, which is developing the novel therapy PVX108 for the safe and convenient treatment of peanut allergy. The study is being conducted under a U....

2023-06-01 20:00 1897

Sky's the limit with Fiji Airways' global sale

Fiji Airways launches up to 38% off return airfares from Canada to Fiji, Australia, New Zealand and Pacific Islands. NADI, Fiji, June 1, 2023 /PRNewswire/ -- Guests can score up to 38% off Fiji Airways flights to popular destinations includingFiji, Pacific Islands, New Zealand and Australia wit...

2023-06-01 12:27 2289

Actinogen to present progress on Cognitive Impairment in Depression and Alzheimer's Disease Phase 2 trials at the BIO International Convention

Xanamem® is an oral, brain-penetrant tissue cortisol synthesis inhibitor that has shown promising safety and clinical activity in three placebo-controlled trials and has the potential to treat a variety of neurodegenerative and neuropsychiatric diseases SYDNEY, May 31, 2023 /PRNewswire/ -- Actin...

2023-05-31 20:58 2273

QBIOTICS TO PRESENT AT SACHS 9TH ANNUAL IMMUNO-ONCOLOGY INNOVATION FORUM AND THE BIO INTERNATIONAL CONVENTION

BRISBANE, Australia, May 31, 2023 /PRNewswire/ -- QBiotics Group Limited ( QBiotics), a clinical stage life sciences company developing novel small molecule anticancer and wound healing pharmaceuticals is pleased to announce thatRichard Godfrey will present to potential partners and investors at t...

2023-05-31 19:00 2725

AMP945 Combined with FOLFIRINOX Enhances Treatment Effects in model of Pancreatic Cancer

HIGHLIGHTS * Amplia's highly selective FAK inhibitor AMP945, when used in combination with FOLFIRINOX, enhances survival in a preclinical model of pancreatic cancer * FOLFIRINOX is the most widely used treatment for pancreatic cancer patients in the US,Canada and most European countries * T...

2023-05-29 16:51 2952

FivepHusion Announces Strategic Collaboration with Treehill Partners and Syneos Health

Supporting FivepHusion's Global Development and Commercialization Strategy SYDNEY, May 26, 2023 /PRNewswire/ -- FivepHusion, an advanced clinical-stage biotechnology company, today announced its collaboration with Treehill Partners, aNew York-based strategic and financial advisory firm specializi...

2023-05-26 13:42 2253

Telix to Host Briefing with U.S. Leadership Team and Key Opinion Leaders to Highlight Innovation in Urology

June 21, 2023, at The Yale Club, New York City The Company will showcase its urologic pipeline, development of novel therapeutics, imaging agents and technologies that aim to harness the power of targeted radiation at every step of the patient journey MELBOURNE, Australia and INDIANAPOLIS, May 2...

2023-05-25 19:00 2012

TYK2/JAK1 Inhibitor AC-201 of Accropeutics Bioscience gained Human Research Ethics Committees (HREC) permission for Phase I

SUZHOU, China, May 24, 2023 /PRNewswire/ -- Accropeutics Bioscience announced that its oral small molecule TYK2/JAK1 inhibitor AC-201 has been approved by the Australian Human Research Ethics Committee (HREC) to launch a clinical phase I trial inAustralia. The trial will be a randomized, double-b...

2023-05-25 09:51 2029

Clarity's theranostic prostate cancer trial advances to cohort 2

Highlights * Cohort 1 of the SECuRE trial has been completed in 6 participants with metastatic castrate-resistant prostate cancer (mCRPC) who received therapy with 67Cu SAR-bisPSMA at the lowest dose level of 4GBq. * No dose limiting toxicities (DLTs) have been reported in cohort 1. * The Sa...

2023-05-24 21:03 2718

Blue Star on track for first helium production and sales from Voyager in Q4 CY2023

PERTH, Australia, May 22, 2023 /PRNewswire/ -- Blue Star Helium Limited (ASX:BNL, OTCQB:BSNLF) ("Blue Star" or the "Company") provides an update on progress at its maiden Voyager helium development inLas Animas County, Colorado. Highlights: * Three well drilling program at high-grade Voyager d...

2023-05-22 13:17 2326

TargetRecruit Expands its Global Presence with New Office in Sydney

SYDNEY, May 18, 2023 /PRNewswire/ -- TargetRecruit, a leading provider of enterprise software for recruitment firms, built on Salesforce, is thrilled to announce the opening of its new office here inSydney. Situated in the heart of Sydney's Central Business District (CBD), the new office will ...

2023-05-18 06:00 2218

Matt Hill Projects Expands, Reimagines Art/Sculptures for Commercial & Residential Spaces

MELBOURNE, Australia and LOS ANGELES, May 16, 2023 /PRNewswire/ -- Matt Hill Projects is recognized as a leading designer and fabricator of steel sculptures ranging from custom animals to illuminated cubes and spheres along with architectural facades, and the company is expanding rapidly due to h...

2023-05-16 21:17 2001

Symbio's South-East Asia Hub unlocks multi-country access with one interconnect

SYDNEY, May 16, 2023 /PRNewswire/ -- Symbio Holdings Limited (ASX: SYM), a leading voice communications software provider, today announced the launch of itsSouth-East Asia (SEA) Regional Hub. Launching across Singapore and Malaysia initially, Symbio's SEA Regional Hub will provide cost efficient,...

2023-05-16 20:00 2168

Symbio to unlock Malaysia domestic communications market with network launch

SYDNEY, May 12, 2023 /PRNewswire/ -- Industry-leading communications software and cloud infrastructure provider Symbio Holdings (ASX:SYM) officially launched its domestic network inMalaysia today, with live call traffic and several large global customers already trialling it. Symbio's entry in...

2023-05-12 20:00 3049
1 ... 78910111213 ... 55

Week's Top Stories